Literature DB >> 10195941

Mutations in promoter region of thrombomodulin and venous thromboembolic disease.

L Le Flem1, V Picard, J Emmerich, S Gandrille, J N Fiessinger, M Aiach, M Alhenc-Gelas.   

Abstract

The present study was designed to analyze the thrombomodulin proximal promoter region spanning nucleotides -293 to -12 to search for polymorphisms that could modify thrombomodulin gene expression in patients with venous thromboembolic disease. The study population comprised 205 patients and 394 healthy subjects of similar age and sex distribution. No polymorphisms and only 1 point mutation (G-33A) were found. The G-33A mutation was present at the heterozygous state in 2 patients and in 1 control. Being more frequent in the patients (0.97%) than in the controls (0.25%), the G-33A mutation might be a risk factor for venous thrombosis. To investigate the effect of this mutation on the thrombomodulin promoter activity, the proximal promoter region of the gene (bearing or not bearing the G-33A mutation) was inserted into a promotorless expression vector, upstream of the firefly luciferase gene, and transiently transfected into EA.hy926 endothelial cells. Under the conditions of the assay, the G-33A mutation mildly decreased the promoter activity. This study confirms that abnormalities of the thrombomodulin proximal promoter are not frequent in patients with venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195941     DOI: 10.1161/01.atv.19.4.1098

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

2.  Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.

Authors:  Yu-Lin Ko; Lung-An Hsu; Tsu-Shiu Hsu; Chia-Ti Tsai; Ming-Sheng Teng; Semon Wu; Chi-Jen Chang; Ying-Shiung Lee
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

3.  Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.

Authors:  Hyunjoo Cha-Molstad; Guanlan Xu; Junqin Chen; Gu Jing; Martin E Young; John C Chatham; Anath Shalev
Journal:  Mol Pharmacol       Date:  2012-06-25       Impact factor: 4.436

4.  Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease.

Authors:  Andrew Srisuwananukorn; Rasha Raslan; Xu Zhang; Binal N Shah; Jin Han; Michel Gowhari; Robert E Molokie; Victor R Gordeuk; Santosh L Saraf
Journal:  Blood Adv       Date:  2020-05-12

5.  Thrombomodulin gene polymorphisms in brain infarction and mortality after stroke.

Authors:  Jean-Marc Olivot; Julien Labreuche; Thomas De Broucker; Odette Poirier; François Cambien; Martine Aiach; Pierre Amarenco
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

6.  Common genetic risk factors for venous thrombosis in the Chinese population.

Authors:  Liang Tang; Hua-Fang Wang; Xuan Lu; Xiao-Rong Jian; Bi Jin; Hong Zheng; Yi-Qing Li; Qing-Yun Wang; Tang-Chun Wu; Huan Guo; Hui Liu; Tao Guo; Jian-Ming Yu; Rui Yang; Yan Yang; Yu Hu
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

Review 7.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

8.  Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

Authors:  Rashmi Sood; Mark Zogg; Randal J Westrick; Yi-He Guo; Edward J Kerschen; Guillermina Girardi; Jane E Salmon; Shaun R Coughlin; Hartmut Weiler
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

9.  How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Olga Arkova; Petr Ponomarenko; Valentin Suslov; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

10.  A Thrombomodulin Gene Polymorphism (C1418T) Is Associated with Early Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery with a Conventional Cardiopulmonary Bypass during Hospitalization.

Authors:  Ching-Chou Pai; Yi-Wen Lin; Yi-Ting Tsai; Shih-Hurng Loh; Chih-Yuan Lin; Chin-Sheng Lin; Yi-Chang Lin; Hung-Yen Ke; Feng-Yen Lin; Chien-Sung Tsai
Journal:  Medicines (Basel)       Date:  2017-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.